Sangamo Therapeutics (SGMO) Stock Price, Quote & News

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 970 6000

Website: www.sangamo.com

Address:

501 Canal Blvd, Richmond, United States

notnowson Oct. 7 at 2:17 AM

$SGMO SANDY

0 · Reply

Prittykitty Oct. 7 at 12:07 AM

$SGMO crsp basing for years. Gonna go 100 in 2026. Most GE companies getting supercharged. A rising tide lifts all boats. Entering the beginning of gene therapy as normality.

1 · Reply

Swamp_Yankee Oct. 6 at 11:27 PM

$SGMO https://www.txs.uscourts.gov/page/bankruptcy-court

0 · Reply

Swamp_Yankee Oct. 6 at 11:26 PM

$SGMO Sandy, hard at work!

0 · Reply

809trader Oct. 6 at 11:22 PM

$SGMO nice volume after hours

0 · Reply

Swamp_Yankee Oct. 6 at 11:20 PM

$SGMO The kooks on this board have turned to bashing shareholders. Well done! As the company and pathetic CEO dries you out and ends up in bankruptcy where you will get fucked so hard you won't know what to do. LMFAO.

0 · Reply

Crash_Bash Oct. 6 at 10:44 PM

$SGMO is tomorrow the day? Sandy you love Tuesdays PRs lets do it foe all the investors that have waited this long.

0 · Reply

John8886 Oct. 6 at 10:04 PM

$SGMO Honest guess is that they diluted already

0 · Reply

John8886 Oct. 6 at 9:54 PM

$SGMO Its so frustrating to look at the broader market and here we are groundhogin every single day, imma press the bearish button for the first time. Expecting dilution again.

0 · Reply

Swamp_Yankee Oct. 6 at 9:45 PM

$SGMO It's going to be difficult for me not to dump a shit ton of shares tomorrow. At least 50 to 75k. There's too much money to be made elsewhere. Sandy and Sangamo are a disaster.

2 · Reply

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025

Aug 8, 2025, 2:53 PM EDT - 2 months ago

Sangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 2 months ago

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results

Jul 31, 2025, 4:05 PM EDT - 2 months ago

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Jun 24, 2025, 8:05 AM EDT - 3 months ago

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

May 12, 2025, 9:06 PM EDT - 5 months ago

Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript

May 12, 2025, 6:26 PM EDT - 5 months ago

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results

May 12, 2025, 6:23 PM EDT - 5 months ago

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering

May 12, 2025, 4:00 PM EDT - 5 months ago

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

May 6, 2025, 4:35 PM EDT - 5 months ago

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

May 6, 2025, 8:30 AM EDT - 5 months ago

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

Apr 28, 2025, 4:31 PM EDT - 5 months ago

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Apr 4, 2025, 2:57 PM EDT - 6 months ago

Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal

Apr 3, 2025, 4:01 PM EDT - 6 months ago

Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System

Mar 17, 2025, 6:29 PM EDT - 7 months ago

Sangamo Therapeutics, Inc. (SGMO) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 4:01 PM EDT - 7 months ago

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Mar 6, 2025, 4:05 PM EST - 7 months ago

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

Feb 6, 2025, 8:05 AM EST - 8 months ago

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

Jan 15, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sangamo Therapeutics, Inc. (SGMO) And Encourages Shareholders to Reach Out

Jan 14, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Shareholders to Learn More About the Investigation

Jan 13, 2025, 10:00 AM EST - 9 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 12, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Shareholders to Inquire about Securities Investigation

Jan 10, 2025, 10:00 AM EST - 9 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 9, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Investors to Connect

Jan 8, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Stockholders to Inquire about Securities Investigation

Jan 7, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Investors to Learn More About the Investigation

Jan 6, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Stockholders to Connect

Jan 5, 2025, 10:00 AM EST - 9 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 3, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Stockholders to Learn More About the Investigation

Jan 2, 2025, 6:00 PM EST - 9 months ago

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Jan 2, 2025, 4:00 PM EST - 9 months ago

Sangamo Therapeutics, Inc. (SGMO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Jan 2, 2025, 3:05 PM EST - 9 months ago

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Jan 2, 2025, 10:15 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Investors to Inquire about Securities Investigation

Dec 31, 2024, 12:01 PM EST - 9 months ago

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

Dec 31, 2024, 11:22 AM EST - 9 months ago

Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact

PFE

notnowson Oct. 7 at 2:17 AM

$SGMO SANDY

0 · Reply

Prittykitty Oct. 7 at 12:07 AM

$SGMO crsp basing for years. Gonna go 100 in 2026. Most GE companies getting supercharged. A rising tide lifts all boats. Entering the beginning of gene therapy as normality.

1 · Reply

Swamp_Yankee Oct. 6 at 11:27 PM

$SGMO https://www.txs.uscourts.gov/page/bankruptcy-court

0 · Reply

Swamp_Yankee Oct. 6 at 11:26 PM

$SGMO Sandy, hard at work!

0 · Reply

809trader Oct. 6 at 11:22 PM

$SGMO nice volume after hours

0 · Reply

Swamp_Yankee Oct. 6 at 11:20 PM

0 · Reply

Crash_Bash Oct. 6 at 10:44 PM

$SGMO is tomorrow the day? Sandy you love Tuesdays PRs lets do it foe all the investors that have waited this long.

0 · Reply

John8886 Oct. 6 at 10:04 PM

$SGMO Honest guess is that they diluted already

0 · Reply

John8886 Oct. 6 at 9:54 PM

$SGMO Its so frustrating to look at the broader market and here we are groundhogin every single day, imma press the bearish button for the first time. Expecting dilution again.

0 · Reply

Swamp_Yankee Oct. 6 at 9:45 PM

$SGMO It's going to be difficult for me not to dump a shit ton of shares tomorrow. At least 50 to 75k. There's too much money to be made elsewhere. Sandy and Sangamo are a disaster.

2 · Reply

Spider217 Oct. 6 at 7:47 PM

$SGMO For Sandy as CEO to go radio silent when his company is on the brink of disaster is unbelievable. No respect for all of us who are loyal shareholders. I cannot believe the board of directors who are supposed to protect shareholders interest are sitting quietly. I am a large shareholder for a long time but we do need clarity on this like yesterday. The board has to react!!!

3 · Reply

biotech Oct. 6 at 7:43 PM

$SGMO october 7-9

1 · Reply

biotech Oct. 6 at 7:43 PM

$SGMO

0 · Reply

Crash_Bash Oct. 6 at 7:33 PM

$SGMO October 22nd, 2024 where all fun started last year and lasted for 1 month. Hopefully history repeat to the exact date!!! Sandy lets do this!

0 · Reply

TheFrenchBuzz Oct. 6 at 7:03 PM

$SGMO’s situation is precarious.

0 · Reply

Newbilly Oct. 6 at 7:01 PM

$SGMO Sandals navigating the rough and rocky world of biotech

0 · Reply

John8886 Oct. 6 at 6:56 PM

$SGMO Ok 0.33% chance of fabry tonight

2 · Reply

Newbilly Oct. 6 at 6:47 PM

$SGMO Sandpistol, got any news brewing for AH

1 · Reply

PedroCarrico Oct. 6 at 5:59 PM

$SGMO The stock has risen 25% in 30 days with no news. Could it go up 50% in 15 days without any new developments?

0 · Reply

ican Oct. 6 at 5:58 PM

$SGMO ok looking at the chart to be objective. since May any pullbacks have been in price. Over the last week, the pullback has been in time. There has been a change in behavior. I have to remind myself patience.

0 · Reply

Qq3344 Oct. 6 at 5:45 PM

$SGMO there will be a stock split

1 · Reply

Patrick2343 Oct. 6 at 5:19 PM

$SGMO SM will have us a fabry deal by November of 2029

1 · Reply

Market Cap	206.04M
Revenue (ttm)	57.80M
Net Income (ttm)	-97.94M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-169.45%
Debt to Equity Ratio	0.00

Volume	4,668,700
Avg Vol	5,664,196
Day's Range	N/A - N/A
Shares Out	301.71M
Stochastic %K	65%
Beta	1.22
Analysts	Strong Sell
Price Target	$4.10